psychiatryRounds

Connecting Psychiatry - Expert community for all mental health professionals

Report from SNM: PET imaging of brain chemistry bolsters characterization of dementias

(PSYCHIATRIC TIMES) - Imaging scientists achieved a major breakthrough when they proved it was possible to predict the onset of Alzheimer's disease using PET scans of neurochemical activity. University of Michigan researchers are going for the next neuroimaging milestone by showing that the same technique can also aid in the differential diagnosis of dementia.

"Our preliminary results clearly indicate that molecular imaging technologies such as PET scans can help diagnose a patient's specific type of dementia," said principal investigator Dr. Kirk A. Frey, codirector of the Movement Disorders Clinic at the University of Michigan.

Frey and colleagues enrolled 66 patients with mild cognitive impairment or mild dementia who underwent a standard neurological assessment and structural imaging of the brain. Based on test results, three experts diagnosed these patients with Alzheimer's disease, frontotemporal dementia, or dementia with Lewy bodies.

Patients also underwent molecular imaging with carbon-11 Pittsburgh Compound B (PIB) to measure amyloid plaque deposits and carbon-11 dihydrotetrabenazine (DTBZ) PET to determine dopamine receptor integrity.

The investigators found both PIB- and DTBZ-PET led to a revised, more accurate diagnosis of dementia in at least one of every four patients. Results were reported at the 2009 SNM meeting in Toronto.

Researchers diagnosed patients with frontotemporal dementia if their PIB- and DTBZ-PET scans were normal. Patients with significant striatum defects on DTBZ-PET were diagnosed as having dementia with Lewy bodies. An Alzheimer's diagnosis, on the other hand, was handed down to patients with normal DTBZ-PET but increased frontal cortical binding on PIB-PET.

PET provided images of important disease indicators that other examinations missed. Examples included amyloid plaques, a common indicator of Alzheimer's disease, and damage to dopamine nerves, which is often observed in Lewy body dementia.

For full article, please visit:
http://www.psychiatrictimes.com/alzheimer-dementia/article/113619/1...

Views: 4

Comment

You need to be a member of psychiatryRounds to add comments!

Join psychiatryRounds


psychiatryRounds Social Media

Sponsors

CMEinfo: Board Reviews in Anesthesia, Cardiology, Internal Medicine, Radiology

© 2019   Created by PsychiatryRounds Team.   Powered by

Badges  |  Report an Issue  |  Terms of Service